Atjaunināt sīkdatņu piekrišanu

Biotechnologies for Gene Therapy: RNA, CRISPR, Nanobots, and Preclinical Applications 2022 ed. [Hardback]

Edited by , Edited by
  • Formāts: Hardback, 203 pages, height x width: 235x155 mm, weight: 494 g, 23 Illustrations, color; 3 Illustrations, black and white; IX, 203 p. 26 illus., 23 illus. in color., 1 Hardback
  • Izdošanas datums: 03-Jun-2022
  • Izdevniecība: Springer Nature Switzerland AG
  • ISBN-10: 3030933326
  • ISBN-13: 9783030933326
Citas grāmatas par šo tēmu:
  • Hardback
  • Cena: 145,08 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Standarta cena: 170,69 €
  • Ietaupiet 15%
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Hardback, 203 pages, height x width: 235x155 mm, weight: 494 g, 23 Illustrations, color; 3 Illustrations, black and white; IX, 203 p. 26 illus., 23 illus. in color., 1 Hardback
  • Izdošanas datums: 03-Jun-2022
  • Izdevniecība: Springer Nature Switzerland AG
  • ISBN-10: 3030933326
  • ISBN-13: 9783030933326
Citas grāmatas par šo tēmu:

The purpose of this book is to highlight some of latest developments and applications of CRISPR, RNA, and DNA to treat diseases ranging from cancers to cardiovascular and degenerative disorders. It also features innovations of the delivery methods for nucleic acids ranging from nanodevices made from DNA and pseudo amino acids to viral vectors. This is an ideal book for academics, clinicians, and students interested in gene therapy.

1. Therapeutic potential of microRNAs and their nanoparticle-based
delivery in the treatment of liver fibrosis.- 2. MicroRNA as a versatile
regulator of Wnt signaling pathway in colorectal cancer.- 3. Small Activating
RNA Therapy for Angiogenesis.- 4. Muscular dystrophy therapy using viral
vector-based CRISPR/Cas.- 5. CRISPR-Cas based gene therapy to target viral
infections.- 6. CRISPR targeting the integrated HTLV-1 virus.- 7. Retroviral
vectors for gene therapy of monogenic diseases.- 8. DNA Origami Nanodevices
for Therapeutic Delivery Applications.
Dr. Yang Yun is an Associate Professor in the Biomedical Engineering Department at the University of Akron. His research interested include biomaterials, cancer therapy, drug and gene delivery, electrospinning, nanotechnology, tissue engineering, and the treatment of infectious diseases. Dr. Kristine Yoder is  an Associate Professor in the department of Cancer Biology and Genetics at Ohio State University.